Skip to content

Prolactin Hormone in Oral Lichen Planus

Prolactin Hormone in Oral Lichen Planus Tissue Samples

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04785703
Enrollment
40
Registered
2021-03-08
Start date
2020-06-19
Completion date
2020-12-10
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus

Brief summary

Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.

Interventions

None listed

Sponsors

Al-Azhar University
CollaboratorOTHER
October University for Modern Sciences and Arts
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients with oral lichen planus * systemically healthy

Exclusion criteria

* oral lichenoid lesions

Design outcomes

Primary

MeasureTime frameDescription
prolactin receptors expression in oral mucous membrane24 hoursimmuno-histochemistry

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026